Search for: "MERRELL"
Results 201 - 220
of 601
Sorted by Relevance
|
Sort by Date
5 Nov 2008, 8:48 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993)] analysis. [read post]
18 Jan 2008, 2:34 am
Merrell Dow Pharmaceuticals, Inc. [read post]
18 Jan 2008, 2:34 am
Merrell Dow Pharmaceuticals, Inc. [read post]
25 Jan 2012, 6:42 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 113 S.Ct. 2786 (1993), and discussed in Taylor v. [read post]
30 May 2017, 10:10 am
Merrell Dow Pharmaceuticals Inc. [read post]
27 Oct 2016, 10:27 am
Merrell Dow Pharmaceuticals, in which the Supreme Court established the standards for the use of expert and scientific evidence in federal courts. [read post]
15 Jul 2010, 5:08 am
Merrell Dow Pharms., Inc., 509 U.S. 579 (1993), to strike plaintiffs’ expert report on the grounds that the expert’s “wobble decay standard was unreliable because it was not supported by empirical testing, was not developed through a recognized standard-setting procedure, was not generally accepted in the relevant scientific, technical, or professional community, and was not the product of independent research. [read post]
18 Jul 2012, 4:34 pm
Keane CJ questioned at [38] to [40] whether the proposition from Merrell Dow that infringement did not depend on the infringer’s state of mind was in fact “absolute” and noted that, in circumstances where a prescription only drug was being prescribed by medical practitioners, the purpose of administration should be reasonably ascertainable. [read post]
28 Jun 2013, 11:05 am
Merrell Dow Pharmaceuticals, 509 U.S. 579 (1993) and codified in Federal Rule of Civil Procedure 702, Daubert recedes from Frye’s “general acceptance” test, and instead focuses on the reliability of the expert’s methodology and the propriety of its application in a given case. [read post]
23 Nov 2011, 7:05 am
While it was never approved for use in the United States, evidence suggests that American women still took it thanks to a marketing scheme by an American drug distributor, Richardson-Merrell. [read post]
27 Apr 2014, 3:25 pm
Merrell Dow Pharm., Inc., 509 U.S. 579 (1993). [read post]
7 Apr 2007, 6:04 am
Merrell Dow Pharmaceutical • "Can we identify the sexual predator by use of penile plethysmography? [read post]
14 May 2010, 10:13 am
Merrell Dow Pharms., 509 U.S. 579, 592, 113 S. [read post]
24 Feb 2012, 8:58 am
Merrell Dow Pharmaceuticals by not soliciting expert testimony to assess the reliability of the defendant’s predictive coding technology. [read post]
22 Feb 2011, 7:27 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), in analyzing the expert presentations relating to the Rule 23 requirements, Plaintiffs contend that the Ninth Circuit found this to be no abuse of discretion, and that it did not matter because the district court judge was "guided by Daubert," concluded that the expert opinions were "based on valid principles," and were "sufficiently probative" of the Rule 23 requirements. [read post]
12 Feb 2020, 5:29 pm
Merrell Dow Pharmaceuticals. [read post]
28 Oct 2014, 4:09 am
Also, under Merrell Dow Pharmaceuticals, Inc. v. [read post]
21 Sep 2011, 3:00 am
Merrell Dow Pharms, Inc., 509 U.S. 579 (! [read post]
22 Feb 2011, 7:27 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), in analyzing the expert presentations relating to the Rule 23 requirements, Plaintiffs contend that the Ninth Circuit found this to be no abuse of discretion, and that it did not matter because the district court judge was "guided by Daubert," concluded that the expert opinions were "based on valid principles," and were "sufficiently probative" of the Rule 23 requirements. [read post]
31 Dec 2009, 2:34 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), and its federal and state progeny. [read post]
